Investigating how a specific microRNA affects bone health in older adults
The Role of miR-219a-5p in Bone Metabolism
This study is looking at a tiny molecule called miR-219a-5p to see how it affects bone health in older adults at risk for osteoporosis, with the goal of finding new ways to help strengthen bones and prevent bone loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10791752 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a microRNA called miR-219a-5p in regulating bone metabolism, particularly in older adults who are at risk for osteoporosis. The study aims to uncover the molecular mechanisms that lead to bone loss and identify potential therapeutic targets to enhance bone formation. By examining how miR-219a interacts with a key transcription factor involved in bone health, researchers hope to develop new strategies to combat osteoporosis and improve bone density in aging populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those at risk for osteoporosis or experiencing bone density loss.
Not a fit: Patients who are younger than 21 years old or do not have concerns related to bone health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve bone health and reduce fracture risk in older adults.
How similar studies have performed: Previous research has shown promise in targeting molecular pathways related to bone metabolism, suggesting that this approach could yield significant advancements in osteoporosis treatment.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Monroe, David G — Mayo Clinic Rochester
- Study coordinator: Monroe, David G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.